Načítá se...
Antiplatelet Therapy in Acute Coronary Syndrome
Antiplatelet agents have for decades been used to improve outcomes in patients with acute coronary syndromes and have become increasingly valued, not only for their antithrombotic properties but also for their anti-inflammatory effects. The drug class continues to evolve as novel agents with increas...
Uloženo v:
| Vydáno v: | Eur Cardiol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Radcliffe Cardiology
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6206448/ https://ncbi.nlm.nih.gov/pubmed/30416549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/ecr.2016:34:2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|